|
1
|
Younger EM and Chapman MW: Morbidity at
bone graft donor sites. J Orthop Trauma. 3:192–195. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Milinković ZB, Krneta O, Milicković S,
Dozić D and Curcić A: Are the additional grafts necessary? Acta
Chir Iugosl. 57:69–72. 2010. View Article : Google Scholar
|
|
3
|
Myeroff C and Archdeacon M: Autogenous
bone graft: Donor sites and techniques. J Bone Joint Surg Am.
93:2227–2236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tapety FI, Amizuka N, Uoshima K, Nomura S
and Maeda T: A histological evaluation of the involvement of
Bio-Oss in osteoblastic differentiation and matrix synthesis. Clin
Oral Implants Res. 15:315–324. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schlegel AK: Bio-Oss bone replacement
material. Long-term results with Bio-Oss bone replacement material.
Schweiz Monatsschr Zahnmed. 106:141–149. 1996.(In French, German).
PubMed/NCBI
|
|
6
|
Schlegel AK and Donath K: BIO-OSS-a
resorbable bone substitute? J Long Term Eff Med Implants.
8:201–209. 1998.PubMed/NCBI
|
|
7
|
Fulmer NL, Bussard GM, Gampper TJ and
Edlich RF: Anorganic bovine bone and analogs of bone mineral as
implants for craniofacial surgery: A literature review. J Long Term
Eff Med Implants. 8:69–78. 1998.PubMed/NCBI
|
|
8
|
Amerio P, Vianale G, Reale M, Muraro R,
Tulli A and Piattelli A: The effect of deproteinized bovine bone on
osteoblast growth factors and proinflammatory cytokine production.
Clin Oral Implants Res. 21:650–655. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Diener HC: CGRP as a new target in
prevention and treatment of migraine. Lancet Neurol. 13:1065–1067.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
de Jong PR, Takahashi N, Peiris M, Bertin
S, Lee J, Gareau MG, Paniagua A, Harris AR, Herdman DS and Corr M:
TRPM8 on mucosal sensory nerves regulates colitogenic responses by
innate immune cells via CGRP. Mucosal Immunol. 8:491–504. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sample SJ, Hao Z, Wilson AP and Muir P:
Role of calcitonin gene-related peptide in bone repair after cyclic
fatigue loading. PLoS One. 6:e203862011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hirt D and Bernard GW: CGRP-beta unlike
CGRP-alpha has no osteogenic stimulatory effect in vitro. Peptides.
18:1461–1463. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han N, Zhang DY, Wang TB, Zhang PX and
Jiang BG: Calcitonin gene-related peptide induces proliferation and
monocyte chemoattractant protein-1 expression via extracellular
signal-regulated kinase activation in rat osteoblasts. Chin Med J
(Engl). 123:1748–1753. 2010.PubMed/NCBI
|
|
14
|
Mrak E, Guidobono F, Moro G, Fraschini G,
Rubinacci A and Villa I: Calcitonin gene-related peptide (CGRP)
inhibits apoptosis in human osteoblasts by β-catenin stabilization.
J Cell Physiol. 225:701–708. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ballica R, Valentijn K, Khachatryan A,
Guerder S, Kapadia S, Gundberg C, Gilligan J, Flavell RA and
Vignery A: Targeted expression of calcitonin gene-related peptide
to osteoblasts increases bone density in mice. J Bone Miner Res.
14:1067–6574. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schinke T, Liese S, Priemel M, Haberland
M, Schilling AF, Catala-Lehnen P, Blicharski D, Rueger JM, Gagel
RF, Emeson RB and Amling M: Decreased bone formation and osteopenia
in mice lacking alpha-calcitonin gene-related peptide. J Bone Miner
Res. 19:2049–2056. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Valentijn K, Gutow AP, Troiano N, Gundberg
C, Gilligan JP and Vignery A: Effects of calcitonin gene-related
peptide on bone turnover in ovariectomized rats. Bone. 21:269–274.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han N, Zhang DY, Wang TB, Zhang PX and
Jiang BG: Calcitonin gene-related peptide induces proliferation and
monocyte chemoattractant protein-1 expression via extracellular
signal-regulated kinase activation in rat osteoblasts. Chin Med J
(Engl). 123:1748–1753. 2010.PubMed/NCBI
|
|
19
|
Shih C and Bernard GW: Calcitonin gene
related peptide enhances bone colony development in vitro. Clin
Orthop Relat Res. 335–344. 1997.PubMed/NCBI
|
|
20
|
Xiao H, Huang C, Feng Y and Li R: Research
situation and development of vacuum freeze-drying technology. Chin
Med Equip J. 13:30–32. 2010.
|
|
21
|
Schek RM, Wilke EN, Hollister SJ and
Krebsbach PH: Combined use of designed scaffolds and adenoviral
gene therapy for skeletal tissue engineering. Biomaterials.
27:1160–1166. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang XQ, Chen JG, Gittens S, Chen CJ,
Zhang XL and Zhang ZY: The ectopic study of tissue-engineered bone
with hBMP-4 gene modified bone marrow stromal cells in rabbits.
Chin Med J (Engl). 118:281–288. 2005.PubMed/NCBI
|
|
23
|
Roldán JC, Detsch R, Schaefer S, Chang E,
Kelantan M, Waiss W, Reichert TE, Gurtner GC and Deisinger U: Bone
formation and degradation of a highly porous biphasic calcium
phosphate ceramic in presence of BMP-7, VEGF and mesenchymal stem
cells in an ectopic mouse model. J Craniomaxillofac Surg.
38:423–430. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Durham PL: Inhibition of calcitonin
gene-related peptide function: A promising strategy for treating
migraine. Headache. 48:1269–1275. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Watkins HA, Au M and Hay DL: The structure
of secretin family GPCR peptide ligands: Implications for receptor
pharmacology and drug development. Drug Discov Today. 17:1006–1014.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qi T, Christopoulos G, Bailey RJ,
Christopoulos A, Sexton PM and Hay DL: Identification of N-terminal
receptor activity-modifying protein residues important for
calcitonin gene-related peptide, adrenomedullin, and amylin
receptor function. Mol Pharmacol. 74:1059–1071. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Watkins HA, Rathbone DL, Barwell J, Hay DL
and Poyner DR: Structure-activity relationships for α-calcitonin
gene-related peptide. Br J Pharmacol. 170:1308–1322. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chiba T, Yamaguchi A, Yamatani T, Nakamura
A, Morishita T, Inui T, Fukase M, Noda T and Fujita T: Calcitonin
gene-related peptide receptor antagonist human CGRP-(8–37). Am J
Physiol. 256:E331–E335. 1989.PubMed/NCBI
|
|
29
|
Dennis T, Fournier A, Cadieux A, Pomerleau
F, Jolicoeur FB, St Pierre S and Quirion R: hCGRP8-37, a calcitonin
gene-related peptide antagonist revealing calcitonin gene-related
peptide receptor heterogeneity in brain and periphery. J Pharmacol
Exp Ther. 254:123–128. 1990.PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mendonça G, Mendonça DB, Simões LG, Araújo
AL, Leite ER, Duarte WR, Aragão FJ and Cooper LF: The effects of
implant surface nanoscale features on osteoblast-specific gene
expression. Biomaterials. 30:4053–4062. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang L, Shi X, Zhao R, Halloran BP, Clark
DJ, Jacobs CR and Kingery WS: Calcitonin gene-related peptide
stimulates stromal cell osteogenic differentiation and inhibits
RANKL induced NF-kappaB activation, osteoclastogenesis and bone
resorption. Bone. 46:1369–1379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cornish J, Callon KE, Bava U, Kamona SA,
Cooper GJ and Reid IR: Effects of calcitonin, amylin, and
calcitonin gene-related peptide on osteoclast development. Bone.
29:162–168. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Turksen K, Bhargava U, Moe HK and Aubin
JE: Isolation of monoclonal antibodies recognizing rat
bone-associated molecules in vitro and in vivo. J Histochem
Cytochem. 40:1339–1352. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
van den Beucken JJ, Walboomers XF, Boerman
OC, Vos MR, Sommerdijk NA, Hayakawa T, Fukushima T, Okahata Y,
Nolte RJ and Jansen JA: Functionalization of multilayered
DNA-coatings with bone morphogenetic protein 2. J Control Release.
113:63–72. 2006. View Article : Google Scholar : PubMed/NCBI
|
